ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Action drug joins fight against tough esophageal cancer
Disease control OngoingThis study is testing whether adding a new immunotherapy drug called cadonilimab to standard chemotherapy and radiation can better control locally advanced esophageal cancer that cannot be surgically removed. The trial will enroll 46 patients to see if this combination improves s…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Experimental immune cell therapy tested for tough cancers
Disease control TerminatedThis early-stage study is testing whether immune cells from healthy donors, given along with two other drugs, are safe for people with advanced colorectal, stomach, or hard-to-treat blood cancers. The goal is to see if this combination helps the donor immune cells last longer in …
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Scans spot hidden heart damage from cancer treatment
Knowledge-focused OngoingThis study aims to find early signs of heart damage in cancer patients receiving radiation therapy to the chest. Researchers will use special heart scans and blood tests on 28 participants before, during, and after their radiation treatment. The goal is to learn how to identify p…
Matched conditions: ESOPHAGUS CANCER
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC